U.S. Pharmaceutical Sales - Q3 2012
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q3 2012. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q3 2012 by sales
- Sales Statistics Q3 2012
- Units*
Rank |
Drug |
Sales ($000) |
|
|
1 |
Nexium AstraZeneca |
1,420,907 |
2.93% |
Stats |
2 |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,405,226 |
1.89% |
Stats |
3 ( 2) |
Crestor AstraZeneca |
1,245,527 |
10.74% |
Stats |
4 ( 2) |
Cymbalta
|
1,158,353 |
9.50% |
Stats |
5 ( 2) |
Humira AbbVie Inc. |
1,152,261 |
13.45% |
Stats |
6 ( 2) |
Advair Diskus GlaxoSmithKline |
1,148,611 |
2.10% |
Stats |
7 ( 1) |
Enbrel Amgen Inc. |
1,066,697 |
12.51% |
Stats |
8 ( 2) |
Remicade Janssen Pharmaceuticals, Inc. |
952,068 |
2.02% |
Stats |
9 ( 4) |
Copaxone Teva Pharmaceuticals USA, Inc. |
877,591 |
9.93% |
Stats |
10 ( 1) |
Neulasta Amgen Inc. |
832,784 |
-1.17% |
Stats |
11 ( 1) |
Rituxan Genentech, Inc. |
773,460 |
-5.61% |
Stats |
12 ( 4) |
Atripla Gilead Sciences, Inc. |
692,246 |
1.34% |
Stats |
13 ( 2) |
OxyContin Purdue Pharma LP |
679,924 |
-0.55% |
Stats |
14 ( 3) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
669,882 |
1.31% |
Stats |
15 ( 4) |
Januvia Merck |
651,299 |
7.50% |
Stats |
16 ( 2) |
Avastin Genentech, Inc. |
650,363 |
0.41% |
Stats |
17 ( 7) |
Lantus Sanofi |
556,147 |
4.94% |
Stats |
18 ( 5) |
Truvada Gilead Sciences, Inc. |
551,280 |
1.56% |
Stats |
19 ( 7) |
Lantus Solostar Sanofi |
535,660 |
11.36% |
Stats |
20 ( 2) |
Epogen Amgen Inc. |
526,118 |
-5.18% |
Stats |
21 ( 7) |
Lyrica
|
499,777 |
9.94% |
Stats |
22 ( 9) |
Celebrex
|
492,984 |
12.77% |
Stats |
23 ( 20) |
Singulair Merck |
486,837 |
-62.20% |
Stats |
24 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
469,299 |
-4.29% |
Stats |
25 ( 9) |
Gleevec Novartis Pharmaceuticals Corporation |
454,935 |
10.57% |
Stats |
26 ( 4) |
Herceptin Genentech, Inc. |
450,251 |
-0.84% |
Stats |
27 ( 8) |
Namenda Allergan plc |
432,634 |
6.05% |
Stats |
28 ( 14) |
Suboxone
|
392,977 |
14.63% |
Stats |
29 ( 4) |
Avonex Biogen |
392,159 |
-5.34% |
Stats |
30 ( 3) |
enoxaparin Generic |
388,188 |
-15.96% |
Stats |
31 ( 6) |
Lucentis Genentech, Inc. |
382,048 |
-1.88% |
Stats |
32 |
escitalopram Generic |
381,081 |
-8.48% |
Stats |
33 ( 6) |
OneTouch
|
374,548 |
3.43% |
Stats |
34 ( 2) |
Diovan HCT Novartis Pharmaceuticals Corporation |
372,714 |
-7.39% |
Stats |
35 ( 3) |
Vyvanse Takeda Pharmaceutical Company Limited |
365,023 |
-2.81% |
Stats |
36 ( 7) |
Zetia Merck |
360,711 |
7.06% |
Stats |
37 ( 7) |
AndroGel AbbVie Inc. |
347,674 |
6.38% |
Stats |
38 ( 3) |
methylphenidate Generic |
346,945 |
0.01% |
Stats |
39 ( 18) |
Actos Takeda Pharmaceutical Company Limited |
333,494 |
-41.96% |
Stats |
40 ( 5) |
Lidoderm Endo Pharmaceuticals Inc. |
326,812 |
6.92% |
Stats |
41 ( 7) |
TriCor AbbVie Inc. |
309,635 |
6.40% |
Stats |
42 ( 7) |
Rebif EMD Serono, Inc. |
308,352 |
8.88% |
Stats |
43 ( 3) |
Symbicort AstraZeneca |
307,678 |
4.37% |
Stats |
44 ( 10) |
Novolog Novo Nordisk |
293,893 |
8.83% |
Stats |
45 ( 5) |
Incivek Vertex Pharmaceuticals Incorporated |
293,018 |
-18.72% |
Stats |
46 ( 9) |
Seroquel XR AstraZeneca |
284,299 |
6.05% |
Stats |
47 ( 3) |
Alimta Eli Lilly and Company |
276,306 |
-1.39% |
Stats |
48 ( 8) |
Viagra
|
276,085 |
7.82% |
Stats |
49 ( 8) |
Levemir Novo Nordisk |
274,892 |
7.66% |
Stats |
50 ( 1) |
amphetamine/dextroamphetamine Generic |
272,504 |
-0.97% |
Stats |
51 ( 12) |
NovoLog FlexPen Novo Nordisk |
270,735 |
11.89% |
Stats |
52 ( 12) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
267,692 |
12.06% |
Stats |
53 ( 7) |
Lovaza GlaxoSmithKline |
266,568 |
8.82% |
Stats |
54 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
265,411 |
-1.79% |
Stats |
55 ( 22) |
Varivax Merck |
263,952 |
31.34% |
Stats |
56 ( 3) |
Niaspan AbbVie Inc. |
262,879 |
4.70% |
Stats |
57 ( 10) |
Procrit Janssen Pharmaceuticals, Inc. |
262,659 |
-10.20% |
Stats |
58 ( 8) |
Humalog Eli Lilly and Company |
251,389 |
8.03% |
Stats |
59 ( 1) |
metoprolol Generic |
249,769 |
-0.87% |
Stats |
60 ( 2) |
Neupogen Amgen Inc. |
248,423 |
2.65% |
Stats |
61 ( 9) |
Nasonex Merck |
247,294 |
-9.30% |
Stats |
62 ( 1) |
Flovent HFA GlaxoSmithKline |
237,214 |
-2.46% |
Stats |
63 ( 2) |
Reyataz Bristol-Myers Squibb Company |
236,127 |
1.20% |
Stats |
64 ( 4) |
Isentress Merck |
233,391 |
2.58% |
Stats |
65 ( 6) |
Vytorin Merck |
228,895 |
6.33% |
Stats |
66 ( 1) |
modafinil Generic |
228,428 |
-0.79% |
Stats |
67 ( 3) |
Janumet Merck |
228,307 |
5.21% |
Stats |
68 ( 5) |
Cialis Eli Lilly and Company |
226,446 |
9.05% |
Stats |
69 ( 14) |
acetaminophen/hydrocodone Generic |
226,379 |
18.96% |
Stats |
70 ( 17) |
Gilenya Novartis Pharmaceuticals Corporation |
221,299 |
21.19% |
Stats |
71 ( 2) |
Aranesp Amgen Inc. |
219,796 |
-1.51% |
Stats |
72 ( 3) |
Restasis Allergan plc |
217,097 |
7.35% |
Stats |
73 ( 6) |
Aciphex Eisai Inc. |
215,681 |
10.07% |
Stats |
74 ( 24) |
Victoza Novo Nordisk |
209,163 |
27.22% |
Stats |
75 ( 1) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
209,063 |
3.84% |
Stats |
76 ( 6) |
Orencia Bristol-Myers Squibb Company |
203,359 |
6.17% |
Stats |
77 ( 11) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
203,170 |
11.98% |
Stats |
78 ( 49) |
Eloxatin Sanofi |
203,067 |
-55.33% |
Stats |
79 ( 7) |
VESIcare Astellas Pharma US, Inc. |
201,552 |
9.64% |
Stats |
80 ( 10) |
Dexilant Takeda Pharmaceutical Company Limited |
200,149 |
13.25% |
Stats |
81 ( 9) |
Adderall XR Takeda Pharmaceutical Company Limited |
197,947 |
-7.81% |
Stats |
82 ( 4) |
fentanyl Generic |
196,777 |
-0.39% |
Stats |
83 ( 3) |
Prezista Janssen Pharmaceuticals, Inc. |
196,751 |
1.17% |
Stats |
84 ( ) |
Zostavax Merck |
194,633 |
n/a |
Stats |
85 ( 7) |
Evista
|
189,378 |
9.53% |
Stats |
86 ( 7) |
Benicar Daiichi Sankyo |
188,980 |
9.67% |
Stats |
87 ( ) |
Gardasil Merck |
188,952 |
n/a |
Stats |
88 ( 68) |
Lipitor
|
186,508 |
-67.80% |
Stats |
89 ( 8) |
budesonide Generic |
186,479 |
-3.36% |
Stats |
90 ( 7) |
Synthroid AbbVie Inc. |
185,868 |
12.61% |
Stats |
91 ( ) |
Xolair
|
184,317 |
n/a |
Stats |
92 ( 2) |
Renvela Sanofi |
183,699 |
7.39% |
Stats |
93 ( 4) |
Lunesta Sunovion Pharmaceuticals Inc. |
183,190 |
2.23% |
Stats |
94 ( 10) |
Prevnar 13 Pfizer Inc. |
177,527 |
-5.86% |
Stats |
95 ( 1) |
Xeloda Genentech, Inc. |
176,414 |
5.28% |
Stats |
96 ( ) |
EpiPen 2-Pak
|
174,048 |
n/a |
Stats |
97 ( ) |
Sensipar Amgen Inc. |
172,317 |
n/a |
Stats |
98 ( 7) |
Zyvox Pfizer Inc. |
171,755 |
-1.37% |
Stats |
99 ( 85) |
atorvastatin Generic |
170,506 |
-78.25% |
Stats |
100 ( ) |
Stelara Janssen Pharmaceuticals, Inc. |
169,648 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.